Physician profile
John Lucas
NPI 1093734840
$7,695.24
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,844 · 2020: $1,465 · 2021: $1,459 · 2022: $1,250 · 2023: $584 · 2024: $93.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $677.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $4,641.25 | 2019-2023 | Anastoclip Gc 8cm (Medium) |
| Laminate Medical Technologies INC. | $2,076.23 | 2019-2023 | Vasq External Support |
| Avenu Medical INC. | $220.56 | 2019 | |
| W. L. Gore & Associates, INC. | $205.71 | 2021-2023 | Gore Acuseal Vascular Graft |
| Venturemed Group, INC. | $170.34 | 2022-2024 | Flex Vessel Prep System |
| Fresenius USA Marketing, INC. | $143.96 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $82.24 | 2021 | |
| Medtronic, INC. | $80.31 | 2023 | In.Pact Admiral |
| Medistim USA, INC. | $58.06 | 2022 | |
| Stemline Therapeutics INC. | $16.58 | 2023 | Orserdu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lucas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.